69 results
8-K
EX-99.1
BJDX
Bluejay Diagnostics Inc
20 Jun 24
Bluejay Diagnostics Announces Reverse Stock Split
4:10pm
statements in this press release include, without limitation, the expected nature and timing of the Company’s planned FDA submission and related plans
8-K
EX-10.1
2vd8qpnxj94g54nfgrm2
31 May 24
Entry into a Material Definitive Agreement
5:24pm
8-K
EX-10.2
8jjztm 2if3s4e5
31 May 24
Entry into a Material Definitive Agreement
5:24pm
8-K
EX-10.3
ey54wu4
31 May 24
Entry into a Material Definitive Agreement
5:24pm
8-K
EX-10.1
8jph3v2
2 Jan 24
Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering
5:21pm
8-K
EX-99.2
99br13l5wbcppqysvwr
2 Jan 24
Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering
5:21pm
8-K
EX-99.1
sajcv1 6k4sq0viq72
2 Jan 24
Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering
5:21pm
424B4
7oy s3ej83ni7vxwq
29 Dec 23
Prospectus supplement with pricing info
5:06pm
8-K
EX-99.1
6kasz5s
27 Dec 23
Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating
9:14am